BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6633505)

  • 1. [3H]acetylcholine binding sites in brain. Effect of disulfide bond modification.
    Schwartz RD; Kellar KJ
    Mol Pharmacol; 1983 Nov; 24(3):387-91. PubMed ID: 6633505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain.
    Martino-Barrows AM; Kellar KJ
    Mol Pharmacol; 1987 Feb; 31(2):169-74. PubMed ID: 3807893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
    Marks MJ; Stitzel JA; Romm E; Wehner JM; Collins AC
    Mol Pharmacol; 1986 Nov; 30(5):427-36. PubMed ID: 3534542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain nicotinic acetylcholine receptors. Biochemical characterization by neosurugatoxin.
    Yamada S; Isogai M; Kagawa Y; Takayanagi N; Hayashi E; Tsuji K; Kosuge T
    Mol Pharmacol; 1985 Aug; 28(2):120-7. PubMed ID: 2862574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of thiol- and disulfide groups in agonist and antagonist binding to the muscarinic receptor.
    Hedlund B; Bartfai T
    Mol Pharmacol; 1979 May; 15(3):531-44. PubMed ID: 492144
    [No Abstract]   [Full Text] [Related]  

  • 6. Agonist and antagonist binding of muscarinic acetylcholine receptors purified from porcine brain: interconversion of high- and low-affinity sites by sulfhydryl reagents.
    Berstein G; Haga K; Haga T; Ichiyama A
    J Neurochem; 1988 Jun; 50(6):1687-94. PubMed ID: 3373209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfide bond reduction inhibits norepinephrine accumulation in postganglionic sympathetic nerve endings.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Aug; 222(2):419-23. PubMed ID: 7097562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oxidizing and reducing analogs of acetylcholine on neuronal nicotinic receptors.
    Xie Y; Jones GS; Loring RH
    Mol Pharmacol; 1992 Aug; 42(2):356-63. PubMed ID: 1301068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of noncompetitive inhibitors with nicotinic receptors in the rat brain.
    Takayama H; Majewska MD; London ED
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1083-9. PubMed ID: 2600805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thio-group modification and Ca2+ on agonist-specific state transitions of a central nicotinic acetylcholine receptor.
    Lukas RJ; Morimoto H; Bennett EL
    Biochemistry; 1979 May; 18(11):2384-95. PubMed ID: 444464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfhydryl modification of two nicotinic binding sites in mouse brain.
    Stitzel JA; Campbell SM; Collins AC; Marks MJ
    J Neurochem; 1988 Mar; 50(3):920-8. PubMed ID: 3339366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of angiotensin II receptors in bovine adrenal cortex by dithiothreitol: further evidence for the essential nature of disulfide bonds.
    Chang RS; Lotti VJ; Keegan ME
    Biochem Pharmacol; 1982 May; 31(10):1903-6. PubMed ID: 6285929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: role of disulfide and sulfhydryl groups.
    Dewar KM; Reader TA
    J Neurochem; 1989 Feb; 52(2):472-82. PubMed ID: 2463335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification and reactivity of sulfhydryls and disulfides of rat brain nicotinic-like acetylcholine receptors.
    Lukas RJ; Bennett EL
    J Biol Chem; 1980 Jun; 255(12):5573-7. PubMed ID: 7380827
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of disulfide bond reduction on the excitatory and inhibitory postsynaptic responses of Aplysia ganglion cells.
    Sato T; Sato M; Sawada M
    Jpn J Physiol; 1976; 26(5):471-85. PubMed ID: 189109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
    Hernandez CM; Terry AV
    Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disulfide bonds in the cholinoreceptors of frog sympathetic ganglion neurons].
    Trinus KF; Skok VI
    Neirofiziologiia; 1979; 11(6):593-600. PubMed ID: 514418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of a disulfide bond in the binding of flunitrazepam to the benzodiazepine receptor from bovine cerebral cortex.
    Otero de Bengtsson MS; Lacorazza HD; Biscoglio de Jiménez Bonino MJ; Medina JH
    J Neurochem; 1993 Feb; 60(2):536-42. PubMed ID: 8380435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.